Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy

Despite the great potential of anti-PD-L1 antibodies for immunotherapy, their low response rate due to an immunosuppressive tumor microenvironment has hampered their application. To address this issue, we constructed a cell membrane-coated nanosystem (mB4S) to reverse an immunosuppressive microenvir...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhilin Li (Author), Qianfeng Zhang (Author), Zhiqian Li (Author), Long Ren (Author), Dayi Pan (Author), Qiyong Gong (Author), Zhongwei Gu (Author), Hao Cai (Author), Kui Luo (Author)
Format: Book
Published: Elsevier, 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_70ce0f1e01b14ffc8c29e5c2c878ea83
042 |a dc 
100 1 0 |a Zhilin Li  |e author 
700 1 0 |a Qianfeng Zhang  |e author 
700 1 0 |a Zhiqian Li  |e author 
700 1 0 |a Long Ren  |e author 
700 1 0 |a Dayi Pan  |e author 
700 1 0 |a Qiyong Gong  |e author 
700 1 0 |a Zhongwei Gu  |e author 
700 1 0 |a Hao Cai  |e author 
700 1 0 |a Kui Luo  |e author 
245 0 0 |a Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy 
260 |b Elsevier,   |c 2024-05-01T00:00:00Z. 
500 |a 2211-3835 
500 |a 10.1016/j.apsb.2024.02.006 
520 |a Despite the great potential of anti-PD-L1 antibodies for immunotherapy, their low response rate due to an immunosuppressive tumor microenvironment has hampered their application. To address this issue, we constructed a cell membrane-coated nanosystem (mB4S) to reverse an immunosuppressive microenvironment to an immuno-supportive one for strengthening the anti-tumor effect. In this system, Epirubicin (EPI) as an immunogenic cell death (ICD) inducer was coupled to a branched glycopolymer via hydrazone bonds and diABZI as a stimulator of interferon genes (STING) agonist was encapsulated into mB4S. After internalization of mB4S, EPI was acidic-responsively released to induce ICD, which was characterized by an increased level of calreticulin (CRT) exposure and enhanced ATP secretion. Meanwhile, diABZI effectively activated the STING pathway. Treatment with mB4S in combination with an anti-PD-L1 antibody elicited potent immune responses by increasing the ratio of matured dendritic cells (DCs) and CD8+ T cells, promoting cytokines secretion, up-regulating M1-like tumor-associated macrophages (TAMs) and down-regulating immunosuppressive myeloid-derived suppressor cells (MDSCs). Therefore, this nanosystem for co-delivery of an ICD inducer and a STING agonist achieved promotion of DCs maturation and CD8+ T cells infiltration, creating an immuno-supportive microenvironment, thus potentiating the therapy effect of the anti-PD-L1 antibody in both 4T1 breast and CT26 colon tumor mice. 
546 |a EN 
690 |a Glycopolymer 
690 |a Polymer prodrug 
690 |a Immunogenic cell death 
690 |a Nanoassembly 
690 |a Epirubicin 
690 |a STING pathway 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Acta Pharmaceutica Sinica B, Vol 14, Iss 5, Pp 2194-2209 (2024) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2211383524000443 
787 0 |n https://doaj.org/toc/2211-3835 
856 4 1 |u https://doaj.org/article/70ce0f1e01b14ffc8c29e5c2c878ea83  |z Connect to this object online.